Reflection Interfit Shell, 52 MM OD, 3 HOLE, REF 71336052, QTY 1, STERILE R, Smith & Nephew, Inc. Indications for use include cemented or uncemented total hip arthroplasty for rheumatoid arthritis; osteoarthritis; post traumatic arthritis, avascular necrosis; femoral and neck fractures; osteomyelitis; fracture, dislocation of the hip; and unsuccessful cup arthroplasty, endoprosthesis, femoral osteotomy, or girdlestone resection.
Published March 5, 2014 · Recall initiated: January 23, 2014
Summary
FDA records medical device Class II recall Z-1066-2014, published March 5, 2014 and initiated January 23, 2014. Recalling firm: Smith & Nephew Inc; Status: Terminated; Reported quantity: 10 units; Lot: Batch No. 13EM03053. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Inner spherical radius of the shell is undersized.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Smith & Nephew Inc
- Distributor
- Worldwide Distribution: US Distribution to NJ and FL; and the countries of: Colombia and Costa Rica.
- Lot
- Batch No. 13EM03053
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAsmith&nephew LEGION OXINIUM POSTERIOR STABILIZED NONPOROUS FEMORAL COMPONENT, SIZE 5N, RIGHT, NARROW, REFNovember 6, 2024
- FDAsmith&nephew LEIGON OXINIUM CONSTRAINED NONPOROUS FEMORAL COMPONENT, SIZE 4 LEFT, REF 71421164; PROSTHESIS,November 6, 2024
- FDAsmith&nephew GENESIS II NONPOROUS POSTERIOR STABILIZED FEMORAL COMPONENT, SIZE 5 LEFT, REF 71421015; UncoatedNovember 6, 2024
- FDAsmith&nephew LEIGON OXINIUM CONSTRAINED NONPOROUS FEMORAL COMPONENT, SIZE 3 LEFT, REF 71421163; PROSTHESIS,November 6, 2024
- FDACATH PACK; REF: DYNJ40904; Packaged in Mexico for Medline Industries, Inc., Mundelein, IL 60060;March 5, 2014
- FDARenasys EZ, a Canister Component of of Renasys EZ Negative Pressure Wound Therapy SystemMarch 5, 2014
Questions about this recall
Was Reflection Interfit Shell, 52 MM OD, 3 HOLE, REF 71336052, QTY 1, STERILE R, Smith & Nephew, Inc. Indications for use include cemented or uncemented total hip arthroplasty for rheumatoid arthritis; osteoarthritis; post traumatic arthritis, avascular necrosis; femoral and neck fractures; osteomyelitis; fracture, dislocation of the hip; and unsuccessful cup arthroplasty, endoprosthesis, femoral osteotomy, or girdlestone resection. recalled?
Yes. FDA published recall Z-1066-2014 on March 5, 2014. Reported hazard: Inner spherical radius of the shell is undersized.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail